InvestorsHub Logo
Followers 25
Posts 1513
Boards Moderated 0
Alias Born 12/14/2006

Re: MinnieM post# 108

Tuesday, 03/29/2011 10:28:42 PM

Tuesday, March 29, 2011 10:28:42 PM

Post# of 306
The CEPH deal with Mesoblast did not seem to hurt their valuation and it could bring a big spotlight onto the sector as the big fish are bitting. In 5 years I bet we will be talking about the stem cell bubble and how we should have bought more in 2011, lol ...

Valeant Pharmaceuticals (VRX) offers to buy drugmaker Cephalon (CEPH) for ~$5.7B in cash, or $73/share, approx. 29% above its 30-day trading average.


Everything I state is just my own opinion so do your own DD.

Buying great stocks is important but buying great stocks at a great price is even more important.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MESO News